UNRESECTABLE LOCALLY ADVANCED UROTHELIAL CANCER

Clinical trials for UNRESECTABLE LOCALLY ADVANCED UROTHELIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE LOCALLY ADVANCED UROTHELIAL CANCER trials appear

Sign up with your email to follow new studies for UNRESECTABLE LOCALLY ADVANCED UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Global trial aims to extend lives in advanced bladder cancer

Disease control Ongoing

This large, global study is testing whether adding one or two immunotherapy drugs (durvalumab and tremelimumab) to standard chemotherapy works better than chemotherapy alone for people with advanced bladder cancer that cannot be removed by surgery. The main goal is to see if thes…

Matched conditions: UNRESECTABLE LOCALLY ADVANCED UROTHELIAL CANCER

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

UNRESECTABLE LOCALLY ADVANCED UROTHELIAL CANCER

Get alerted when new UNRESECTABLE LOCALLY ADVANCED UROTHELIAL CANCER trials appear

Global trial aims to extend lives in advanced bladder cancer